SMA Migraine Data Lead Neuro Highlights from AAN Meeting

SMA, Migraine Data Lead Neuro Highlights from AAN Meeting

17:10 EDT 7 May 2019 | Xconomy

The American Academy of Neurology meeting in Philadelphia is rolling on through the end of this week. There has been plenty of news to digest already. New clinical data could herald cutting-edge treatments for migraine, the rare disease spinal muscular atrophy, the deadly neurological disorder amyotrophic lateral sclerosis, and more. Xconomy previewed the conference last […]

Original Article: SMA, Migraine Data Lead Neuro Highlights from AAN Meeting

More From BioPortfolio on "SMA, Migraine Data Lead Neuro Highlights from AAN Meeting"